60 related articles for article (PubMed ID: 98893)
1. Effects of drugs and lesions on dopamine-stimulated adenylate cyclase: evidence for different classes of dopamine receptors.
Katzman R; Makman MH; Ahn HS; Mishra RK; Gardner E
Trans Am Neurol Assoc; 1977; 102():76-9. PubMed ID: 98893
[No Abstract] [Full Text] [Related]
2. [Blockade of the dopamine receptor: a possible mechanism of action of antipsychotic drugs (author's transl)].
Karobath ME
Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):151-61. PubMed ID: 1233518
[TBL] [Abstract][Full Text] [Related]
3. Repartition and drug sensitivity of dopamine and L-isoproterenol-sensitive adenylate cyclases in rat brain homogenates.
Prémont J; Tassin JP; Thierry AM; Bockaert J
Adv Biochem Psychopharmacol; 1976; 15():347-56. PubMed ID: 192054
[TBL] [Abstract][Full Text] [Related]
4. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
Psychopharmacol Bull; 1986; 22(3):593-8. PubMed ID: 2879302
[No Abstract] [Full Text] [Related]
5. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
6. Amine-responsive adenylate cyclase activity from brain: comparisons between rat and rhesus monkey and demonstration of dopamine-stimulated adenylate cyclase in monkey neocortex.
Weinryb I; Michel IM
Psychopharmacol Commun; 1976; 2(1):39-48. PubMed ID: 822479
[TBL] [Abstract][Full Text] [Related]
7. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
Gnegy ME; Bernabei A; Treisman G
J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
[TBL] [Abstract][Full Text] [Related]
8. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
[TBL] [Abstract][Full Text] [Related]
9. Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.
Spano PF; Govoni S; Trabucchi M
Adv Biochem Psychopharmacol; 1978; 19():155-65. PubMed ID: 358777
[No Abstract] [Full Text] [Related]
10. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.
Clark D; White FJ
Synapse; 1987; 1(4):347-88. PubMed ID: 2971273
[TBL] [Abstract][Full Text] [Related]
11. Site-specific blockade of dopamine receptors by neuroleptic agents in human brain.
Borison RL; Fields JZ; Diamond BI
Neuropharmacology; 1981 Dec; 20(12B):1321-2. PubMed ID: 6119643
[No Abstract] [Full Text] [Related]
12. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Hornykiewicz O
Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
[No Abstract] [Full Text] [Related]
13. Further evidence for the existence of multiple receptors for dopamine in the central nervous system.
Iversen LL; Quik M; Emson PC; Dowling JE; Watling KJ
Adv Biochem Psychopharmacol; 1980; 21():193-202. PubMed ID: 6103646
[No Abstract] [Full Text] [Related]
14. Inhibition of dopamine-sensitive adenylate cyclase in rat basal ganglia and other hormone sensitive adenylate cyclase systems by neuroleptic drugs.
Miller R
Br J Pharmacol; 1975 Mar; 53(3):457P-458P. PubMed ID: 1137755
[No Abstract] [Full Text] [Related]
15. Dopamine-sensitive adenylyl cyclase: a receptor mechanism for dopamine.
Kebabian JW
Adv Biochem Psychopharmacol; 1978; 19():131-54. PubMed ID: 29445
[No Abstract] [Full Text] [Related]
16. Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors.
Rosenfeld MR; Makman MH; Ahn HS; Thal LJ; Mishra RK; Katzman R
Adv Biochem Psychopharmacol; 1980; 23():83-93. PubMed ID: 6249092
[TBL] [Abstract][Full Text] [Related]
17. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
18. Detection of multiple receptors for dopamine.
Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
[No Abstract] [Full Text] [Related]
19. Central nervous system dopamine receptors.
Creese I
Adv Biochem Psychopharmacol; 1980; 21():235-42. PubMed ID: 6103649
[No Abstract] [Full Text] [Related]
20. Adenylate cyclase from various dopaminergic areas of the brain and the action of loxapine.
Clement-Cormier YC
Adv Exp Med Biol; 1977; 90():183-90. PubMed ID: 930743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
